MiR-4324通过作用于RacGAP1抑制人RCC细胞的增殖

张庆松; 李文贤; 郭磊; 刘勇; 牛海涛; 毛昕

doi:10.13201/j.issn.1001-1420.2021.12.008

MiR-4324通过作用于RacGAP1抑制人RCC细胞的增殖

- 青岛大学附属医院泌尿外科(山东青岛, 260000)

详细信息

通讯作者: 毛昕,E-mail:maoxinqdfy@126.com

中图分类号: R737.11

收稿日期: 2020-07-30

Effects of miR-4324 on inhibiting the growth of human renal cancer cells by suppressing RacGAP1

- Department of Urology, Affiliated Hospital of Qingdao University, Qingdao, Shandong, 260000, China

More Information

Corresponding author: MAO Xin, E-mail: maoxinqdfy@126.com

Received Date: 30 July 2020

摘要

摘要: 目的：观察miR-4324对人RCC细胞生长的影响及作用机制。方法：实时荧光定量聚合酶链反应（qPCR）检测RCC组织和癌旁组织中RacGAP1 mRNA和miR-4324的表达；通过细胞瞬时转染的方式在人RCC细胞中转染miR-4324模拟物和过表达RacGAP1质粒；qPCR检测细胞miR-4324潜在靶基因RacGAP1 mRNA的表达，Western印迹法检测RacGAP1蛋白的表达；采用细胞增殖实验检测细胞增殖能力；采用EdU实验检测细胞增殖活力。结果：qPCR结果显示，与肾小管上皮细胞和正常肾组织相比，RCC细胞和RCC组织中miR-4324表达明显降低，RacGAP1 mRNA表达明显增高；与对照组相比，转染miR-4324分别抑制786-O和CAKI-1细胞中RacGAP1 mRNA的表达，Western蛋白印迹检测结果验证了miR-4324对RacGAP1基因表达的调控；而RCC细胞786-O和CAKI-1细胞中共转染miR-4324模拟物和过表达RacGAP1质粒后，细胞中RacGAP1表达恢复。MTT结果显示，与阴性对照组相比，转染miR-4324模拟物后，细胞增殖能力明显下降；共转染miR-4324模拟物和过表达RacGAP1质粒后，细胞增殖能力逐渐增强。EdU结果显示，与阴性对照组相比，转染miR-4324模拟物的细胞EdU阳性细胞百分比明显减低，表明细胞增殖能力明显下降。双荧光素酶报告基因实验结果显示，在RCC细胞786-O和CAKI-1细胞中miR-4324能够与RacGAP1基因3’UTR特定序列结合从而靶向调控RacGAP1基因的表达。结论：miR-4324能通过靶向结合RacGAP1的3’UTR特定序列抑制其表达，从而显著抑制RCC细胞的增殖。
- miR-4324 /
- RacGAP1基因 /
- 3’UTR /
- 肾细胞癌
Abstract: Objective: To investigate the effects of miR-4324 on the growth of human renal cell carcinoma and its mechanism.Methods: Transient cell transfection was used to overexpress miR-4324 and RacGAP1 gene in human renal cancer cells, and real-time fluorescent quantitative polymerase chain reaction(qPCR) was used to detect the expression of RacGAP1, a potential target gene of miR-4324. RacGAP1 protein expression was detected by Western blotting, and cell proliferation assay was used to detect cell proliferation ability. EdU experiment was used to detect cell proliferation activity.Results: QPCR results showed that compared with renal tubular epithelial cells and normal kidney tissues, the expression of miR-4324 in renal cancer cells and renal cancer tissues were significantly reduced, while the expression of RacGAP1 mRNA was significantly increased. Compared with the control group, miR-4324 inhibited the expression of RacGAP1 mRNA in 786-O and CAKI-1 cells, respectively. Western blotting results verified the regulation of miR-4324 on the expression of RacGAP1 gene, while co-transfected miR-4324 with RacGAP1 in renal cancer cells, the expression of RacGAP1 was restored. The results of cell proliferation assay showed that the cell proliferation ability decreased significantly after miR-4324 transfection compared with the negative control group. After miR-4324 and RacGAP1 co-transfection, the cell proliferation ability gradually increased. EdU results demonstrated that compared with the negative control group, the percentage of EdU-positive cells in miR-4324 group was significantly reduced. The dual-luciferase reporter assay showed that miR-4324 can bind to the 3'UTR specific sequence of RacGAP1 gene in renal cancer cell 786-O and CAKI-1 cells to target and regulate the expression of RacGAP1 gene.Conclusion: MiR-4324 can inhibit the expression of RacGAP1 by targeting the specific sequence of 3'UTR, thereby significantly inhibiting the growth of renal cancer cells.
- miR-4324 /
- RacGAP1 gene /
- 3'UTR /
- renal cell carcinoma

HTML全文

参考文献(13)

[1]	Ricketts CJ, Crooks DR, Sourbier C, et al.SnapShot:Renal Cell Carcinoma[J].Cancer Cell, 2016, 29(4):610-610.e1.
[2]	Lokeshwar SD, Talukder A, Yates TJ, et al.Molecular Characterization of Renal Cell Carcinoma:A Potential Three-MicroRNA Prognostic Signature[J].Cancer Epidemiol Biomarkers Prev, 2018, 27(4):464-472.
[3]	Znaor A, Lortet-Tieulent J, Laversanne M, et al.International variations and trends in renal cell carcinoma incidence and mortality[J].Eur Urol, 2015, 67(3):519-530.
[4]	Lewis BP, Burge CB, Bartel DP.Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets[J].Cell, 2005, 120(1):15-20.
[5]	Yu X, Li Z, Shen J, et al.MicroRNA-10b promotes nucleus pulposus cell proliferation through RhoC-Akt pathway by targeting HOXD10 in intervetebral disc degeneration[J].PLoS One, 2013, 8(12):e83080.
[6]	Vinall RL, Ripoll AZ, Wang S, et al.MiR-34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway status[J].Int J Cancer, 2012, 130(11):2526-2538.
[7]	Zhang X, Hu S, Zhang X, et al.MicroRNA-7 arrests cell cycle in G1 phase by directly targeting CCNE1 in human hepatocellular carcinoma cells[J].Biochem Biophys Res Commun, 2014, 443(3):1078-1084.
[8]	Yin C, Toiyama Y, Okugawa Y, et al.Rac GTPase-Activating Protein 1(RACGAP1) as an Oncogenic Enhancer in Esophageal Carcinoma[J].Oncology, 2019, 97(3):155-163.
[9]	冯倩倩, 袁东方, 高国伟, 等.RACGAP1在肝细胞肝癌中的表达及临床意义[J].现代肿瘤医学, 2020, 28(11):1895-1898.
[10]	Ge Q, Lu M, Ju L, et al.miR-4324-RACGAP1-STAT3-ESR1 feedback loop inhibits proliferation and metastasis of bladder cancer[J].Int J Cancer, 2019, 144(12):3043-3055.
[11]	Lee YS, Dutta A.MicroRNAs in cancer[J].Annu Rev Pathol, 2009, 4:199-227.
[12]	Kasinski AL, Slack FJ.Epigenetics and genetics.MicroRNAs en route to the clinic:progress in validating and targeting microRNAs for cancer therapy[J].Nat Rev Cancer, 2011, 11(12):849-864.
[13]	Schanza LM, Seles M, Stotz M, et al.MicroRNAs Associated with Von Hippel-Lindau Pathway in Renal Cell Carcinoma:A Comprehensive Review[J].Int J Mol Sci, 2017, 18(11):2495.